Table 2.

Effect of 2-Day Gevokizumab Treatment in Goto-Kakisaki Rats

	Ischemia/Reperfusion
	Untreated	Gevokizumab Treated
LV weight, g	0.90 ± 0.02	0.86 ± 0.01
Area at risk, % of LV	43.4 ± 3.0	45.2 ± 4.9
Infarct size, % of LV	16.6 ± 1.8	7.6 ± 1.9∗
LV ESP, mm Hg	93.9 ± 6.8	90.0 ± 5.2
LV ESPVR, mm Hg/RVU	12.5 ± 1.0	16.4 ± 1.0∗
LV EDP, mm Hg	2.06 ± 0.31	1.27 ± 0.15∗
LV EDPVR, mm Hg/RVU	2.15 ± 0.21	1.44 ± 0.17∗

Values are mean ± SD.

Abbreviations as in Table 1.

^∗p <0.05 versus untreated I/R. n = 10 to 15 per group.